Deferoxamine and other iron chelators

Deravi, Niloofar; Norouzkhani, Narges; Keylani, Kimia; Haghi, Seyedeh Mona; Rafiei, Seyyed Kiarash Sadat

doi:10.1016/b978-0-12-824315-2.00591-1

Encyclopedia of Toxicology 2024

DOI: 10.1016/b978-0-12-824315-2.00591-1

|View full text |Cite

Deferoxamine and other iron chelators

Niloofar Deravi¹,

Narges Norouzkhani²,

Kimia Keylani³

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

2025

Publication Types

Select...

Article2

Relationship

Self Cite0

Independent2

Authors

Journals

Cited by 2 publications

References 64 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Deferoxamine-induced neurotoxicity: Role of chaperone-mediated autophagy dysfunction in neuronal apoptosis in the hippocampus

Zhang,

Guo,

Chu

et al. 2025

Chemico-Biological Interactions

View full text Add to dashboard Cite

Deferoxamine-induced neurotoxicity: Role of chaperone-mediated autophagy dysfunction in neuronal apoptosis in the hippocampus

Zhang,

Guo,

Chu

et al. 2025

Chemico-Biological Interactions

View full text Add to dashboard Cite

Iron Overdose in Pregnant Women and its Treatment

Saiyed

2024

AJPS

View full text Add to dashboard Cite

During pregnancy, Iron requirements increase significantly to support the growth of the foetus and placenta, as well as maternal erythropoietic expansion. Iron supplementation is universally recommended for a viable pregnancy, irrespective of maternal Iron status. A food fortification strategy delivering about 10mg Iron per day lowers the proportion of women under risk of Iron deficiency to the range of 6 per cent to 39 per cent in many states. Combining fortification with weekly supplementation would lower the risk to between 1 per cent and 5 per cent. Food fortification and supplementation would expose many women to Iron levels that exceed the tolerable upper level of 45mg per day, producing Iron overload which can be prove to be toxic. Large epidemiological studies show a U-shaped association between maternal ferritin, a marker of Iron stores, and risk of adverse outcomes of pregnancy such as low birthweight, stillbirth, preterm birth (<37 weeks), very preterm birth (<32 weeks’ gestation), and neonatal asphyxia.

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Deferoxamine and other iron chelators

Cited by 2 publications

References 64 publications

Deferoxamine-induced neurotoxicity: Role of chaperone-mediated autophagy dysfunction in neuronal apoptosis in the hippocampus

Deferoxamine-induced neurotoxicity: Role of chaperone-mediated autophagy dysfunction in neuronal apoptosis in the hippocampus

Iron Overdose in Pregnant Women and its Treatment

Contact Info

Product

Resources

About